BAT Considers Reducing Stake in ITC

BAT by 2FIRSTS.ai
Dec.19.2023
BAT Considers Reducing Stake in ITC
British American Tobacco (BAT) is considering reducing its 29.02% stake in ITC, its largest shareholder, according to reports.

In recent days, according to Indian financial media outlet Moneycontrol, British American Tobacco (BAT), the largest shareholder of ITC, is reportedly considering reducing its stake of 29.02% in the conglomerate.

 

According to reports, the current market value of the shares held by British American Tobacco in ITC is 1,63,200 crore Indian Rupees, with each share valued at 451.05 Indian Rupees. If British American Tobacco reduces its equity stake by four percentage points, the total value of the shares it plans to sell will reach approximately 22,500 crore Indian Rupees.

 

In fact, the sale of shares could be seen as an attempt by the British-American Tobacco Company to reduce its debt and comply with India's strict regulations on foreign tobacco companies' ownership. On December 18th, ITC's stock faced pressure and witnessed a intraday decline of 1.5%.

 

In general, ITC lacks any promoters and its major shareholders are foreign institutional investors and domestic institutional investors, who respectively own 43.3% and 42% of the company's shares. According to quarterly data from September, the public holds 14.7% of the company's shares.

 

Significantly important analysts firmly believe that the company will create long-term value for shareholders in the future. "Therefore, we do not anticipate any substantial decline in the stock price in the medium to long term," stated Parth Shah, research analyst at StoxBox Corporation."

 

So, will there be buyers willing to take over these shares?

 

According to Rajat Mehta, the CEO of Mehta Equities, "The domestic fund flow is very strong; Republic Foundation is more than willing to purchase any shares." On this matter, others also concur, believing that domestic institutional investors will see this sale as an opportunity to establish new positions or increase their holdings."

 

Furthermore, CEO of British American Tobacco, Mr. Marroco, believes that the sale of shares in ITC is highly complex due to the restrictions and limitations on foreign ownership imposed by India on domestic tobacco companies.

 

He pointed out, "For any of our actions regarding shares, specific approval from the Reserve Bank of India is required, which adds significant additional bureaucratic procedures." He added that as a result, "the buyer group for ITC shares is limited."

 

Although ITC's stock price may see more upward potential in the future, analysts believe that for the current strategy buyers mentioned in the article, this could be the right move.

 

"Whether the buyer is a single entity or multiple institutional investors, this should not pose a problem, considering ITC's performance in the past few quarters," said Gaurang Shah, Senior Vice President of Geojit Financial.

 

A recent study has found that the performance of tobacco companies is expected to be affected in the short term, but the long-term impact of the recent equity sale is unlikely to be lasting. ITC's long-term driving factors, including a focus on the fast-moving consumer goods sector and improved profitability levels, as well as reducing dependence on the tobacco business, are steadily progressing.

 

Since the beginning of the year, the group's stocks have risen by 34%, propelling ITC to become the world's third-largest tobacco company, surpassing British American Tobacco.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
A Fifth Circuit panel upheld the U.S. Food and Drug Administration’s 2021 final rule requiring companies seeking premarket authorization for new tobacco products to include information on health-risk investigations. In a published opinion, the court found FDA satisfied the Regulatory Flexibility Act’s procedural requirements and reasonably relied on the economic analysis from the 2016 “deeming rule” as a factual basis to certify limited impact on small businesses.
Feb.27 by 2FIRSTS.ai
FRE Nicotine Pouches Partners with Taylor Reimer Racing, Covering Four 2026 ARCA Events
FRE Nicotine Pouches Partners with Taylor Reimer Racing, Covering Four 2026 ARCA Events
FRE® Nicotine Pouches announced a partnership with Taylor Reimer Racing, becoming the Official Nicotine Sponsor for four races in the 2026 ARCA Menards Series and serving as the primary sponsor at events in Alabama, Michigan, Minnesota, and Arizona. FRE branding will appear on the race car, driver suit, and helmet, and the collaboration will also extend to off-track content and activations.
Feb.27
Russia to Start Extrajudicial Blocking of Sites Selling Tobacco and Nicotine Products Online From March 1
Russia to Start Extrajudicial Blocking of Sites Selling Tobacco and Nicotine Products Online From March 1
Russia will introduce an extrajudicial (non-court) blocking mechanism starting March 1, 2026, allowing authorities to block websites selling tobacco and nicotine-containing products online without a court order. State Duma member Anton Nemkin said the change will place offending sites directly onto the prohibited information registry, speeding up enforcement, reducing the court burden, and increasing platform obligations to proactively monitor content.
Jan.29 by 2FIRSTS.ai
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
After France’s ANSES report on nicotine products and harm reduction, Dr. Xin-an Liu wrote to 2Firsts reassessing the field’s foundations. She argues the debate reveals gaps in evidence on long-term behavioral substitution, addiction pathways and neurobiological impacts, and calls for longitudinal research, integrated behavioral science and neuroimaging, clearer risk assessment and stronger transparency to ensure policy and next-generation product development rest on solid evidence.
Industry Insight
Feb.24
Ireland’s 2026 amendment bill to regulate nicotine pouches and tighten rules on vaping products
Ireland’s 2026 amendment bill to regulate nicotine pouches and tighten rules on vaping products
The Irish government has approved the publication of the Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026. The bill would ban the sale of nicotine consumption products such as nicotine pouches to those under 18 and further regulate nicotine vaping products.
Mar.05 by 2FIRSTS.ai
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
During FDA’s Feb 10 PMTA roundtable (manufacturing controls panel), small ENDS manufacturers warned that uncertainty in manufacturing expectations creates existential financial risk. FDA officials reiterated review flexibility is constrained by statutory and scientific boundaries. The panel debated testing standards, documentation requirements, open-system responsibility, supply chain changes, and software updates—highlighting unresolved PMTA challenges for small manufacturers.
Feb.11